USANA Health Sciences Inc (USNA)
Return on equity (ROE)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 63,788 | 59,817 | 63,399 | 65,264 | 69,350 | 76,875 | 89,276 | 108,353 | 116,505 | 135,814 | 138,990 | 128,733 | 124,664 | 115,789 | 109,505 | 102,906 | 100,526 | 102,103 | 108,921 | 121,450 |
| Total stockholders’ equity | US$ in thousands | 497,202 | 470,394 | 468,824 | 455,354 | 434,472 | 411,099 | 403,681 | 389,946 | 395,124 | 399,079 | 418,623 | 402,777 | 441,650 | 389,117 | 349,076 | 317,608 | 351,712 | 314,286 | 384,156 | 391,217 |
| ROE | 12.83% | 12.72% | 13.52% | 14.33% | 15.96% | 18.70% | 22.12% | 27.79% | 29.49% | 34.03% | 33.20% | 31.96% | 28.23% | 29.76% | 31.37% | 32.40% | 28.58% | 32.49% | 28.35% | 31.04% |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $63,788K ÷ $497,202K
= 12.83%
USANA Health Sciences Inc's return on equity (ROE) has shown a fluctuating trend over the period provided. The ROE has ranged from a low of 12.72% in Sep 30, 2023, to a high of 34.03% in Jun 30, 2021. The company's ROE indicates the efficiency of its use of shareholders' equity to generate profits.
The declining trend in ROE from 34.03% in Jun 30, 2021, to 12.72% in Sep 30, 2023 suggests a potential decrease in profitability relative to shareholders' equity over the period. The decrease in ROE could be attributed to various factors such as changes in the company's net income, total equity, or both.
Overall, it is advisable to further investigate the underlying reasons for the fluctuating ROE to understand the company's performance, financial health, and potential areas for improvement. A comprehensive analysis considering additional financial metrics and external factors would provide a more holistic view of USANA Health Sciences Inc's financial performance.